Xeris Pharmaceuticals, INC.

Pharmaceutical company

Based in IL

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $80K in lobbying spend across 13 quarterly filings, Xeris Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2019 to 2024.

$80K
Total Spend
5
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2019$20K
2020$10K
2022$20K
2023$30K
2024$0

Issues Lobbied

Medicare/MedicaidMED

Lobbying Firms

The Conafay Group, LLC

Lobbyists

Julie PawelczykNora Sanzo

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, MED

  • •Support for Part D reimbursement.
  • •Medicare Part D.
  • •Biomedical research issues

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

American Association of Orthopaedic Surgeons
$14.7M total spend
American Academy of Pediatrics
$8.4M total spend
Muscular Dystrophy Association, INC.
$3.5M total spend
American Academy of Orthopaedic Surgeons
$1.2M total spend
Horizon Therapeutics USA INC
$1.2M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.